Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Donor-targeted serotherapy as a rescue therapy for steroid-resistant acute GVHD after HLA-mismatched kidney transplantation.

Zuber J, Boyer O, Neven B, Jollet I, Renac V, Berthaud R, Levy R, Lamarthée B, Visentin J, Marchal A, Gouge-Biebuyck N, Godron-Dubrasquet A, Aladjidi N, Rabah MO, Winter S, Léon J, Dussiot M, Rabant M, Krid S, Krug P, Charbit M, Lacaille F, André I, Cavazzana M, Llanas B, Allard L, Pirenne F, Gross S, Djoudi R, Tiberghien P, Taupin JL, Blanche S, Salomon R.

Am J Transplant. 2020 Feb 17. doi: 10.1111/ajt.15827. [Epub ahead of print]

PMID:
32065452
2.

Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal.

Thein SL, Pirenne F, Fasano RM, Habibi A, Bartolucci P, Chonat S, Hendrickson JE, Stowell SR.

Haematologica. 2020 Mar;105(3):539-544. doi: 10.3324/haematol.2019.224709. Epub 2020 Feb 6. No abstract available.

3.

Complement activation in sickle cell disease: Dependence on cell density, hemolysis and modulation by hydroxyurea therapy.

Roumenina LT, Chadebech P, Bodivit G, Vieira-Martins P, Grunenwald A, Boudhabhay I, Poillerat V, Pakdaman S, Kiger L, Jouard A, Audureau E, Pirenne F, Galactéros F, Frémeaux-Bacchi V, Bartolucci P.

Am J Hematol. 2020 Jan 28. doi: 10.1002/ajh.25742. [Epub ahead of print]

PMID:
31990387
4.

American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support.

Chou ST, Alsawas M, Fasano RM, Field JJ, Hendrickson JE, Howard J, Kameka M, Kwiatkowski JL, Pirenne F, Shi PA, Stowell SR, Thein SL, Westhoff CM, Wong TE, Akl EA.

Blood Adv. 2020 Jan 28;4(2):327-355. doi: 10.1182/bloodadvances.2019001143.

5.

Human Apoptotic Cells, Generated by Extracorporeal Photopheresis, Modulate Allogeneic Immune Response.

Pilon C, Stehlé T, Beldi-Ferchiou A, Matignon M, Thiolat A, Burlion A, Grondin C, Birebent B, Pirenne F, Rouard H, Lang P, Marodon G, Grimbert P, Cohen JL.

Front Immunol. 2019 Dec 18;10:2908. doi: 10.3389/fimmu.2019.02908. eCollection 2019.

6.

The role of Complement in Post-Transfusion Hemolysis and Hyperhemolysis Reaction.

Roumenina LT, Bartolucci P, Pirenne F.

Transfus Med Rev. 2019 Oct;33(4):225-230. doi: 10.1016/j.tmrv.2019.09.007. Epub 2019 Oct 18. Review.

PMID:
31672341
7.

The cause and pathogenesis of hemolytic transfusion reactions in sickle-cell disease.

Pirenne F.

Curr Opin Hematol. 2019 Nov;26(6):488-494. doi: 10.1097/MOH.0000000000000546.

PMID:
31589171
8.

Still celebrate the World Blood Donor Day and shed light on blood donation needs and blood demand.

Garraud O, Follea G, Pirenne F.

Transfus Clin Biol. 2019 Nov;26(4):197. doi: 10.1016/j.tracli.2019.05.005. Epub 2019 Jun 1. No abstract available.

PMID:
31186147
9.

Identification of genetic biomarkers for alloimmunization in sickle cell disease.

Meinderts SM, Gerritsma JJ, Sins JWR, de Boer M, van Leeuwen K, Biemond BJ, Rijneveld AW, Kerkhoffs JH, Habibi A, van Bruggen R, Kuijpers TW, van der Schoot E, Pirenne F, Fijnvandraat K, Tanck MW, van den Berg TK.

Br J Haematol. 2019 Sep;186(6):887-899. doi: 10.1111/bjh.15998. Epub 2019 Jun 5.

PMID:
31168801
10.

A proposal for a rational transfusion strategy in patients of European and North African descent with weak D type 4.0 and 4.1 phenotypes.

Flegel WA, Peyrard T, Chiaroni J, Tournamille C, Jamet D, Pirenne F.

Blood Transfus. 2019 Mar;17(2):89-90. doi: 10.2450/2018.0059-18. Epub 2018 May 3. No abstract available.

11.

Prevention of delayed hemolytic transfusion reaction.

Pirenne F.

Transfus Clin Biol. 2019 May;26(2):99-101. doi: 10.1016/j.tracli.2019.02.007. Epub 2019 Feb 22.

PMID:
30926306
12.

[Transfusion: 10 key messages].

Pirenne F.

Rev Prat. 2018 Nov;68(9):1036. French. No abstract available.

PMID:
30869368
13.

[Transfusion: the case of sickle cell patients].

Pirenne F, Habibi A.

Rev Prat. 2018 Nov;68(9):1034-1035. French. No abstract available.

PMID:
30869367
14.

[Rare blood groups].

Pirenne F.

Rev Prat. 2018 Nov;68(9):1023-1024. French. No abstract available.

PMID:
30869364
15.

Predisposing factors for anti-D immune response in D- patients with chronic liver disease transfused with D+ platelet concentrates.

Burin des Roziers N, Chadebech P, Malard L, Vingert B, Gallon P, Samuel D, Djoudi R, Fillet AM, Pirenne F.

Transfusion. 2019 Apr;59(4):1353-1358. doi: 10.1111/trf.15129. Epub 2019 Jan 3.

PMID:
30604873
16.

Alloimmunization risk associated with amino acid 223 substitution in the RhD protein: analysis in the light of molecular modeling.

de Brevern AG, Floch A, Barrault A, Martret J, Bodivit G, Djoudi R, Pirenne F, Tournamille C.

Transfusion. 2018 Nov;58(11):2683-2692. doi: 10.1111/trf.14809. Epub 2018 Oct 4.

PMID:
30284289
17.

Genotyping in Sickle Cell Disease Patients: The French Strategy.

Floch A, Tournamille C, Chami B, Pirenne F.

Transfus Med Hemother. 2018 Jul;45(4):264-270. doi: 10.1159/000490858. Epub 2018 Jul 6. Review.

18.

Management of the blood supply for a Jk(a-b-) patient with an anti-Jk3 in preparation for an urgent heart transplant: An illustrative example of a successful international cooperation.

Thonier V, Cohen-Bacrie S, Loussert I, Thornton N, Djoudi R, Woimant G, Boulat C, Pirenne F, Peyrard T.

Transfus Clin Biol. 2019 Feb;26(1):48-55. doi: 10.1016/j.tracli.2018.04.002. Epub 2018 May 23.

PMID:
29802018
19.

How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions.

Pirenne F, Yazdanbakhsh K.

Blood. 2018 Jun 21;131(25):2773-2781. doi: 10.1182/blood-2018-02-785964. Epub 2018 May 3. Review.

20.

High immunogenicity of red blood cell antigens restricted to the population of African descent in a cohort of sickle cell disease patients.

Floch A, Gien D, Tournamille C, Chami B, Habibi A, Galactéros F, Bierling P, Djoudi R, Pondarré C, Peyrard T, Pirenne F.

Transfusion. 2018 Jun;58(6):1527-1535. doi: 10.1111/trf.14633. Epub 2018 Apr 29.

PMID:
29707783
21.

[Erratum to "The way forward in transfusion medicine, from a French perspective…" [Transfus. Clin. Biol. (25)(1) (2018)]].

Garraud O, Folléa G, Lassale B, Pirenne F.

Transfus Clin Biol. 2018 May;25(2):148. doi: 10.1016/j.tracli.2018.02.002. Epub 2018 Mar 21. French. No abstract available.

PMID:
29573907
22.

Molecular immunohaematology round table discussions at the AABB Annual Meeting, Orlando 2016.

Flegel WA, Chen Q, Castilho L, Keller MA, Klapper EB, Lane WJ, Pirenne F, Stack G, St-Louis M, Tormey CA, Waxman DA, Weinstock C, Wendel S, Denomme GA.

Blood Transfus. 2018 Sep;16(5):447-456. doi: 10.2450/2018.0260-17. Epub 2018 Feb 14. No abstract available.

23.

The way forward in transfusion medicine, from a French perspective….

Garraud O, Folléa G, Lassale B, Pirenne F.

Transfus Clin Biol. 2018 Feb;25(1):1. doi: 10.1016/j.tracli.2018.01.001. No abstract available. Erratum in: Transfus Clin Biol. 2018 Mar 21;:.

PMID:
29413324
24.

Control of Humoral Response in Renal Transplantation by Belatacept Depends on a Direct Effect on B Cells and Impaired T Follicular Helper-B Cell Crosstalk.

Leibler C, Thiolat A, Hénique C, Samson C, Pilon C, Tamagne M, Pirenne F, Vingert B, Cohen JL, Grimbert P.

J Am Soc Nephrol. 2018 Mar;29(3):1049-1062. doi: 10.1681/ASN.2017060679. Epub 2018 Jan 10.

25.

Anti-CD20 Antibody Prevents Red Blood Cell Alloimmunization in a Mouse Model.

Elayeb R, Tamagne M, Pinheiro M, Ripa J, Djoudi R, Bierling P, Pirenne F, Vingert B.

J Immunol. 2017 Dec 1;199(11):3771-3780. doi: 10.4049/jimmunol.1700754. Epub 2017 Oct 20.

26.

Clinical severity in adult warm autoimmune hemolytic anemia and its relationship to antibody specificity.

Chadebech P, Loustau V, Janvier D, Languille L, Ripa J, Tamagne M, Bierling P, Djoudi R, Godeau B, Michel M, Pirenne F, Mahévas M.

Haematologica. 2018 Jan;103(1):e35-e38. doi: 10.3324/haematol.2017.175976. Epub 2017 Oct 12. No abstract available.

27.

Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease.

Narbey D, Habibi A, Chadebech P, Mekontso-Dessap A, Khellaf M, Lelièvre JD, Godeau B, Michel M, Galactéros F, Djoudi R, Bartolucci P, Pirenne F.

Am J Hematol. 2017 Dec;92(12):1340-1348. doi: 10.1002/ajh.24908. Epub 2017 Oct 31.

28.

Nonclassical FCGR2C haplotype is associated with protection from red blood cell alloimmunization in sickle cell disease.

Meinderts SM, Sins JWR, Fijnvandraat K, Nagelkerke SQ, Geissler J, Tanck MW, Bruggeman C, Biemond BJ, Rijneveld AW, Kerkhoffs JH, Pakdaman S, Habibi A, van Bruggen R, Kuijpers TW, Pirenne F, van den Berg TK.

Blood. 2017 Nov 9;130(19):2121-2130. doi: 10.1182/blood-2017-05-784876. Epub 2017 Sep 12.

PMID:
28899854
29.

Design of the DREPAGREFFE trial: A prospective controlled multicenter study evaluating the benefit of genoidentical hematopoietic stem cell transplantation over chronic transfusion in sickle cell anemia children detected to be at risk of stroke by transcranial Doppler (NCT 01340404).

Chevret S, Verlhac S, Ducros-Miralles E, Dalle JH, de Latour RP, de Montalembert M, Benkerrou M, Pondarré C, Thuret I, Guitton C, Lesprit E, Etienne-Julan M, Elana G, Vannier JP, Lutz P, Neven B, Galambrun C, Paillard C, Runel C, Jubert C, Arnaud C, Kamdem A, Brousse V, Missud F, Petras M, Doumdo-Divialle L, Berger C, Fréard F, Taieb O, Drain E, Elmaleh M, Vasile M, Khelif Y, Bernaudin M, Chadebech P, Pirenne F, Socié G, Bernaudin F.

Contemp Clin Trials. 2017 Nov;62:91-104. doi: 10.1016/j.cct.2017.08.008. Epub 2017 Aug 15.

PMID:
28821470
30.

Management of delayed hemolytic transfusion reaction in sickle cell disease: Prevention, diagnosis, treatment.

Pirenne F, Bartolucci P, Habibi A.

Transfus Clin Biol. 2017 Sep;24(3):227-231. doi: 10.1016/j.tracli.2017.05.016. Epub 2017 Jun 29.

PMID:
28669521
31.

Elevated soluble α-hemoglobin pool in sickle cell anemia.

Vasseur C, Domingues-Hamdi E, Pakdaman S, Barau C, Pissard S, Le Corvoisier P, Pirenne F, Galactéros F, Baudin-Creuza V.

Am J Hematol. 2017 Oct;92(10):E593-E595. doi: 10.1002/ajh.24835. Epub 2017 Jul 24. No abstract available.

32.

Severe hemolysis after plasma transfusion in a neonate with necrotizing enterocolitis, Clostridium perfringens infection, and red blood cell T-polyagglutination.

Moh-Klaren J, Bodivit G, Jugie M, Chadebech P, Chevret L, Mokhtari M, Chamillard X, Gallon P, Tissières P, Bierling P, Djoudi R, Pirenne F, Burin-des-Roziers N.

Transfusion. 2017 Nov;57(11):2571-2577. doi: 10.1111/trf.14196. Epub 2017 Jun 22.

PMID:
28643465
33.

Red blood cells for transfusion in patients with sepsis: respective roles of unit age and exposure to recipient plasma.

Chadebech P, Bodivit G, Razazi K, de Vassoigne C, Pellé L, Burin-des-Roziers N, Bocquet T, Bierling P, Djoudi R, Mekontso-Dessap A, Pirenne F.

Transfusion. 2017 Aug;57(8):1898-1904. doi: 10.1111/trf.14170. Epub 2017 May 31.

PMID:
28568651
34.

Transfusion clinique et biologique: A new era.

Garraud O, Pirenne F.

Transfus Clin Biol. 2017 Feb;24(1):1-2. doi: 10.1016/j.tracli.2017.02.001. No abstract available.

PMID:
28236939
35.

Molecular characterization of 13 new RHD alleles.

Floch A, Barrault A, De Brevern AG, Martret J, Gaillard K, Devaux L, Chami B, Bierling P, Pirenne F, Tournamille C.

Transfusion. 2017 Apr;57(4):1089-1091. doi: 10.1111/trf.14004. Epub 2017 Jan 28. No abstract available.

PMID:
28130782
36.

17th International Haemovigilance Seminar: Paris (France), 9-11 March 2016.

Wood E, Bolton-Maggs P, Faber JC, Schipperus KL, Tomasulo P, Wiersum-Osselton J, Boyeldieu D, Cabaud JJ, Cartron JP, Daban JL, Daurat G, Djoudi R, Faurey D, Folléa G, Gouezec H, Garraud O, Laperche S, Lassale B, Lefort C, Muller JY, Oubouzar N, Pirenne F, Py JY, Renaudier P, Roche C, Sailliol A, Tiberghien P, Tinard X.

Blood Transfus. 2016 Mar 2:s1-s80. doi: 10.2450/2016.S1. [Epub ahead of print] No abstract available.

37.

A diagnostic nomogram for delayed hemolytic transfusion reaction in sickle cell disease.

Mekontso Dessap A, Pirenne F, Razazi K, Moutereau S, Abid S, Brun-Buisson C, Maitre B, Michel M, Galacteros F, Bartolucci P, Habibi A.

Am J Hematol. 2016 Dec;91(12):1181-1184. doi: 10.1002/ajh.24537. Epub 2016 Sep 7.

38.

Molecular immunohaematology round table discussions at the AABB Annual Meeting, Anaheim 2015.

Flegel WA, Castilho L, Heaton WA, Keller MA, Klapper EB, Lane WJ, Pirenne F, Shehata N, Stack G, St-Louis M, Tormey CA, Wagner FF, Waxman DA, Denomme GA.

Blood Transfus. 2016 Nov;14(6):557-565. doi: 10.2450/2016.0063-16. Epub 2016 Jul 29. No abstract available.

39.

Neuraminidase enhances in vitro expansion of human erythroid progenitors.

Bodivit G, Chadebech P, Vigon I, Yacia A, Roziers NB, Pirenne F, Fichelson S.

Eur Cytokine Netw. 2016 Jun 1;27(2):16-26. doi: 10.1684/ecn.2016.0374.

40.

Dense red blood cell and oxygen desaturation in sickle-cell disease.

Di Liberto G, Kiger L, Marden MC, Boyer L, Poitrine FC, Conti M, Rakotoson MG, Habibi A, Khorgami S, Vingert B, Maitre B, Galacteros F, Pirenne F, Bartolucci P.

Am J Hematol. 2016 Oct;91(10):1008-13. doi: 10.1002/ajh.24467. Epub 2016 Aug 4.

41.

Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes.

Habibi A, Mekontso-Dessap A, Guillaud C, Michel M, Razazi K, Khellaf M, Chami B, Bachir D, Rieux C, Melica G, Godeau B, Galacteros F, Bartolucci P, Pirenne F.

Am J Hematol. 2016 Oct;91(10):989-94. doi: 10.1002/ajh.24460. Epub 2016 Jul 14.

42.

Transcriptomic Signature of the CD24hi CD38hi Transitional B Cells Associated With an Immunoregulatory Phenotype in Renal Transplant Recipients.

Bigot J, Pilon C, Matignon M, Grondin C, Leibler C, Aissat A, Pirenne F, Cohen JL, Grimbert P.

Am J Transplant. 2016 Dec;16(12):3430-3442. doi: 10.1111/ajt.13904. Epub 2016 Jul 14.

43.

Evidence of benefits from using fresh and cryopreserved blood to transfuse patients with acute sickle cell disease.

Chadebech P, de Ménorval MA, Bodivit G, Mekontso-Dessap A, Pakdaman S, Jouard A, Galactéros F, Bierling P, Habibi A, Pirenne F.

Transfusion. 2016 Jul;56(7):1730-8. doi: 10.1111/trf.13636. Epub 2016 May 17.

PMID:
27184475
44.

Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients.

Ibanez C, Habibi A, Mekontso-Dessap A, Chadebech P, Chami B, Bierling P, Galactéros F, Rieux C, Nataf J, Bartolucci P, Peyrard T, Pirenne F.

Transfusion. 2016 Jul;56(7):1828-33. doi: 10.1111/trf.13611. Epub 2016 May 3.

PMID:
27145018
45.

Rare and transient anti-D antibody response in D(-) liver transplant recipients transfused with D(+) red blood cells.

Burin des Roziers N, Ibanez C, Samuel D, Francoz C, Idri S, François A, Mortelecque R, Bierling P, Pirenne F.

Vox Sang. 2016 Jul;111(1):107-10. doi: 10.1111/vox.12392. Epub 2016 Feb 25.

PMID:
26918570
46.

[Tribute to Jean-Jacques Lefrère].

Pirenne F.

Transfus Clin Biol. 2016 Feb;23(1):1. doi: 10.1016/j.tracli.2015.11.004. Epub 2016 Jan 5. French. No abstract available.

PMID:
26778840
47.

TIGIT-positive circulating follicular helper T cells and sickle cell alloimmunization.

Pirenne F.

Haematologica. 2015 Nov;100(11):1371-3. doi: 10.3324/haematol.2015.136135. No abstract available.

48.

The role of UV radiation in the prevention of human leukocyte antigen alloimmunization.

Andreu G, Boccaccio C, Klaren J, Lecrubier C, Pirenne F, Garcia I, Baudard M, Devers L, Fournel JJ.

Transfus Med Rev. 1992 Jul;6(3):212-24. Review. No abstract available.

PMID:
1498466
49.

The effect of ultraviolet B light on antigen-presenting cells: implications for transfusion-induced sensitization.

Andreu G, Perrot JY, Pirenne F, Boccaccio C.

Semin Hematol. 1992 Apr;29(2):122-31. Review. No abstract available.

PMID:
1594944

Supplemental Content

Loading ...
Support Center